Last reviewed · How we verify
Humulin® Regular
At a glance
| Generic name | Humulin® Regular |
|---|---|
| Also known as | Reference drug |
| Sponsor | Geropharm |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Nasal Insulin to Fight Forgetfulness - Device Study (PHASE2)
- SNIFF Multi-Device Study 2 (PHASE2)
- Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
- Effect of High Dose Insulin on Infectious Complications Following Major Surgery (NA)
- Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (PHASE2, PHASE3)
- High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes (NA)
- Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy (PHASE3)
- Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Humulin® Regular CI brief — competitive landscape report
- Humulin® Regular updates RSS · CI watch RSS
- Geropharm portfolio CI